About this trial
A new clinical entity of eosinophilic esophagitis, Food Induced Immediate Response of the Esophagus or FIRE, has been described since 2020. Diagnostic criteria are not clearly established. Specific questioning is necessary for differential diagnosis, such as the oro-pharyngeal syndrome notably described in pollinics, or a mechanical blockage strictly speaking linked to esophagitis. The aim is to obtain epidemiological data on this entity.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients over 6 and under 18 years of age at the time of inclusion
Follow-up in the allergology unit of Angers University Hospital for eosinophilic esophagitis
Disqualifiers
Patients or legal representative with severe communication or language comprehension difficulties
Patients or legal representatives objecting to study participation
Trial population
Patient follow-up in the allergology unit of Angers University Hospital
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
diagnosis of FIRE syndrome
symptoms such as pain, pressure, choking or narrowing, in the oesophagus or retrosternum, within 10 minutes of ingestion, lasting a maximum of 120 minutes, when a specific food is ingested
Sponsors and contacts
Click on the lead sponsor to view all of their trials.